There were a lot of good posts yesterday about what the management (especially Joe) had done, not done and could have done. But the reality still is that for most investors, penny stocks, especially OTC stocks, are nothing but “shiny objects”. We on this board know the full spectrum of GNBT/NGIO potential (laid out from 2019), but most 2020 new investors only see GNBT as a Covid vaccine shiny object. With the so called promise of a vaccine by Nov. 1st or by the end of the year, GNBT is no longer a shiny object, hence the latest pps. We know the science behind a successful vaccine and realize that in all probability, the front runners will fail. They are running a marathon at a one mile sprinters pace. Investors will cheer them on (with their money) until the front runners collapse in failure, and only then will they see the “race” for what it is and start backing the true participants. By then GNBT/NGIO will have proven the science behind the “complete vaccine” and become the new front runner. Until then, any CCs and PRs about the Covid vaccine will not attract new investors, but CCs and PRs about the original 2019 corporation vision could. Remember that no one (including me, also underwater) has lost any money until they sell their shares for less than they bought them. So for me, let the original 2019 vision be my guide. The newly added Covid vaccine will resolve itself when the front runners start falling flat on their faces.
(7)
(0)
Generex Biotechnology Corp. (GNBTQ) Stock Research Links